Back | Next |
home / stock / nrbo / nrbo message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts gaining | SmellMyFinger | investorshub | 01/14/2024 7:01:12 PM |
$NRBO MomentumIts gaining | SmellMyFinger | investorshub | 01/14/2024 3:47:40 AM |
The trading | BJ-Trader | investorshub | 01/14/2024 3:43:51 AM |
$NRBO Price gaining last trade up | SmellMyFinger | investorshub | 01/14/2024 2:31:01 AM |
$NRBO MomentumIts trading | BesaoT35 | investorshub | 01/13/2024 10:39:37 PM |
$NRBO MomentumIts gaining | tw0122 | investorshub | 01/13/2024 9:52:05 PM |
$NRBO MomentumIts now last trade up | BesaoT35 | investorshub | 01/13/2024 8:14:49 PM |
Good read | SmellMyFinger | investorshub | 01/13/2024 7:45:42 PM |
Price trading last trade up | SmellMyFinger | investorshub | 01/13/2024 7:23:05 PM |
$NRBO Found an interesting article | BesaoT35 | investorshub | 01/13/2024 4:39:43 PM |
short squeeze all day | subslover | investorshub | 01/13/2024 4:17:14 PM |
The gaining up | friendVA | investorshub | 01/13/2024 1:35:54 PM |
short squeeze all day | SmellMyFinger | investorshub | 01/13/2024 1:15:14 PM |
$NRBO The trading up | SmellMyFinger | investorshub | 01/12/2024 7:47:50 PM |
$NRBO short data if anyone is interested | FROZENFLAME | investorshub | 01/12/2024 6:40:39 PM |
Thoughts on where this is headed? | tw0122 | investorshub | 01/12/2024 6:02:19 PM |
$NRBO The gaining up | Karlchen | investorshub | 01/12/2024 5:07:43 PM |
Price trading last up | BesaoT35 | investorshub | 01/12/2024 4:25:41 PM |
$NRBO is it bear time? Or do we go bull? | BesaoT35 | investorshub | 01/12/2024 3:29:29 PM |
When is this gonna take off? | gr8investment | investorshub | 01/12/2024 3:06:03 PM |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...
NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in...